Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society

被引:0
|
作者
Rodacki, Melanie [1 ]
Zajdenverg, Lenita [1 ]
da Silva Jr, Wellington Santana [2 ]
Giacaglia, Luciano [3 ]
Negrato, Carlos Antonio [4 ]
Cobas, Roberta Arnoldi [5 ]
de Almeida-Pititto, Bianca [6 ]
Bertoluci, Marcello Casaccia [7 ]
机构
[1] Univ Fed Rio De Janeiro, Dept Clin Med Nutrol, Rio De Janeiro, Brazil
[2] Univ Fed Maranhao, Dept Med 1, Disciplina Endocrinol, Sao Luis, Brazil
[3] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil
[4] Univ Sao Paulo, Fac Med Bauru, Bauru, Brazil
[5] Univ Estado Rio De Janeiro, Fac Ciencias Med, Dept Med Interna, Rio De Janeiro, Brazil
[6] Univ Fed Sao Paulo, Dept Med Prevent, Escola Paulista Med, Sao Paulo, Brazil
[7] Univ Fed Rio Grande do Sul, Serv Endocrinol Hosp Clin Porto Alegre, Fac Med, Porto Alegre, Brazil
来源
DIABETOLOGY & METABOLIC SYNDROME | 2025年 / 17卷 / 01期
关键词
Practice guidelines: type 2 diabetes mellitus; Prediabetic state; Blood glucose; Glycated hemoglobin; Oral glucose tolerance test; Diagnosis; Early diagnosis; Disease prevention; FASTING PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; METABOLIC SYNDROME; OBESE CHILDREN; TOLERANCE TEST; LIFE-STYLE; FOLLOW-UP; OGTT; PREVALENCE;
D O I
10.1186/s13098-024-01572-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with type 2 diabetes (T2D) often experience prolonged periods of asymptomatic hyperglycemia, which significantly increases the risk of developing chronic complications related to diabetes. Screening programs for individuals at high risk for T2D provide valuable opportunities not only for early diagnosis but also for detecting intermediate hyperglycemic states, commonly referred to as prediabetes. Interventions aimed at preventing diabetes in this group can successfully delay or even avoid the onset of the disease and its associated burdens. This review is an update of the Brazilian Diabetes Society (Sociedade Brasileira de Diabetes [SBD]) evidence-based guideline for diagnosing diabetes and screening T2D. Methods The methodology was previously published and defined by the internal institutional steering committee. The working group drafted the manuscript by selecting vital clinical questions for a narrative review, utilizing MEDLINE via PubMed to identify relevant studies. The review assessed the best available evidence, including randomized clinical trials (RCTs), meta-analyses, and high-quality observational studies related to the diagnosis of diabetes. Results and conclusions Fifteen specific recommendations were formulated. Screening is recommended for adults aged 35 and older or younger individuals with obesity and additional risk factors. For children and adolescents, screening is recommended starting at age ten or the onset of puberty if they are overweight or obese and have additional risk factors. Fasting plasma glucose (FPG) and HbA1c are recommended as initial screening tests. The oral glucose tolerance test (OGTT) is recommended for high-risk individuals with normal HbA1c and FPG or those with prediabetes. The 1-h OGTT is preferred over the 2-h OGTT, as it is both more practical and a superior test. A structured approach to reevaluation intervals is provided.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus
    Bertoluci, Marcello Casaccia
    Nunes Salles, Joao Eduardo
    Silva-Nunes, Jose
    Pedrosa, Hermelinda Cordeiro
    Moreira, Rodrigo Oliveira
    Calado da Silva Duarte, Rui Manuel
    Costa Carvalho, Davide Mauricio
    Trujilho, Fabio Rogerio
    Cancela dos Santos Raposo, Joao Filipe
    Parente, Erika Bezerra
    Valente, Fernando
    de Moura, Fabio Ferreira
    Hohl, Alexandre
    Melo, Miguel
    Pestana Araujo, Francisco Garcia
    Monteiro Castro de Araujo Principe, Rosa Maria
    Kupfer, Rosane
    Costa e Forti, Adriana
    Valerio, Cynthia Melissa
    Ferreira, Helder Jose
    Sequeria Duarte, Joao Manuel
    Kerr Saralva, Jose Francisco
    Rodacki, Melanie
    Costa Gurgel Castelo, Maria Helane
    Monteiro, Mariana Pereira
    Branco, Patricia Quadros
    Patricio de Matos, Pedro Manuel
    de Melo Pereira de Magalhaes, Pedro Carneiro
    Barcellos Betti, Roberto Tadeu
    Rea, Rosangela Roginski
    Guedes Trujilho, Thaisa Dourado
    Ferreira Pinto, Lana Catani
    Leitao, Cristiane Bauermann
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01):
  • [32] A consensus statement from the Japan Diabetes Society: A proposed algorithm for pharmacotherapy in people with type 2 diabetes
    Bouchi, Ryotaro
    Kondo, Tatsuya
    Ohta, Yasuharu
    Goto, Atsushi
    Tanaka, Daisuke
    Satoh, Hiroaki
    Yabe, Daisuke
    Nishimura, Rimei
    Harada, Norio
    Kamiya, Hideki
    Suzuki, Ryo
    Yamauchi, Toshimasa
    JDS Comm Consensus Statement Dev
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (01) : 151 - 164
  • [33] Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)
    Moreira, Rodrigo Oliveira
    Valerio, Cynthia Melissa
    Villela-Nogueira, Cristiane Alves
    Cercato, Cintia
    Gerchman, Fernando
    Lottenberg, Ana Maria Pita
    Godoy-Matas, Amelio Fernando
    Oliveira, Ricardo de Andrade
    Mello, Carlos Eduardo Brandao
    Alvares-da-Silva, Mario Reis
    Leite, Nathalie Carvalho
    Cotrim, Helma Pinchemel
    Parisi, Edison Roberto
    Silva, Giovanni Faria
    Miranda, Paulo Augusto Carvalho
    Halpern, Bruno
    Oliveira, Claudia Pinto
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67
  • [34] Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society
    Araki, Eiichi
    Tanaka, Atsushi
    Inagaki, Nobuya
    Ito, Hiroshi
    Ueki, Kohjiro
    Murohara, Toyoaki
    Imai, Kenjiro
    Sata, Masataka
    Sugiyama, Takehiro
    Ishii, Hideki
    Yamane, Shunsuke
    Kadowaki, Takashi
    Komuro, Issei
    Node, Koichi
    DIABETOLOGY INTERNATIONAL, 2021, 12 (01) : 1 - 51
  • [35] Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society
    Eiichi Araki
    Atsushi Tanaka
    Nobuya Inagaki
    Hiroshi Ito
    Kohjiro Ueki
    Toyoaki Murohara
    Kenjiro Imai
    Masataka Sata
    Takehiro Sugiyama
    Hideki Ishii
    Shunsuke Yamane
    Takashi Kadowaki
    Issei Komuro
    Koichi Node
    Diabetology International, 2021, 12 : 1 - 51
  • [36] Diagnosis, Prevention, and Treatment of Cardiovascular Diseases in People With Type 2 Diabetes and Prediabetes - A Consensus Statement Jointly From the Japanese Circulation Society and the Japan Diabetes Society -
    Araki, Eiichi
    Tanaka, Atsushi
    Inagaki, Nobuya
    Ito, Hiroshi
    Ueki, Kohjiro
    Murohara, Toyoaki
    Imai, Kenjiro
    Sata, Masataka
    Sugiyama, Takehiro
    Ishii, Hideki
    Yamane, Shunsuke
    Kadowaki, Takashi
    Komuro, Issei
    Node, Koichi
    CIRCULATION JOURNAL, 2021, 85 (01) : 82 - 125
  • [37] Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
    Seferovic, Petar M.
    Petrie, Mark C.
    Filippatos, Gerasimos S.
    Anker, Stefan D.
    Rosano, Giuseppe
    Bauersachs, Johann
    Paulus, Walter J.
    Komajda, Michel
    Cosentino, Francesco
    de Boer, Rudolf A.
    Farmakis, Dimitrios
    Doehner, Wolfram
    Lambrinou, Ekaterini
    Lopatin, Yuri
    Piepoli, Massimo F.
    Theodorakis, Michael J.
    Wiggers, Henrik
    Lekakis, John
    Mebazaa, Alexandre
    Mamas, Mamas A.
    Tschoepe, Carsten
    Hoes, Arno W.
    Seferovic, Jelena P.
    Logue, Jennifer
    McDonagh, Theresa
    Riley, Jillian P.
    Milinkovic, Ivan
    Polovina, Marija
    van Veldhuisen, Dirk J.
    Lainscak, Mitja
    Maggioni, Aldo P.
    Ruschitzka, Frank
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (05) : 853 - 872
  • [38] DIABETES CONTROL AND COMPLICATIONS TRIAL - POSITION STATEMENT OF THE AUSTRALIAN-DIABETES-SOCIETY
    YUE, DK
    COLAGIURI, S
    MCELDUFF, A
    SILINK, M
    MEDICAL JOURNAL OF AUSTRALIA, 1993, 159 (11-12) : 803 - 804
  • [39] Position Statement of the Chinese Diabetes Society regarding stem cell therapy for diabetes
    Zhu, Dalong
    Chen, Li
    Hong, Tianpei
    JOURNAL OF DIABETES, 2012, 4 (01) : 18 - 21
  • [40] 22nd Brazilian Diabetes Society Congress
    Diabetology & Metabolic Syndrome, 11